Protein detail

BMPR2

Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II)

Protein symbol
BMPR2
UniProt ID
EVMP score
0.50
Frequency
1
Transmembrane count
1
Protein classification
Disease related genesEnzymesFDA approved drug targetsHuman disease related genesPredicted membrane proteins
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II)
Protein Class
Disease related genesEnzymesFDA approved drug targetsHuman disease related genesPredicted membrane proteins
Protein Function
  • Human disease related genes:Cardiovascular diseases:Vascular diseases
  • ENZYME proteins:Transferases
  • Human disease related genes:Cardiovascular diseases:Hypertensive diseases
  • Enzymes
  • Kinases:TKL Ser/Thr protein kinases
  • Disease related genes
  • FDA approved drug targets:Biotech drugs
Transmembrane
151..171; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym
BMPR-IIBMPR3BRK-3PPH1T-ALK
Gene Description
Bone morphogenetic protein receptor type 2
Chromosome
2
Position
202376327-202567751
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
Function & Pathway
Protein Function
  • Human disease related genes:Cardiovascular diseases:Vascular diseases
  • ENZYME proteins:Transferases
  • Human disease related genes:Cardiovascular diseases:Hypertensive diseases
  • Enzymes
  • Kinases:TKL Ser/Thr protein kinases
  • Disease related genes
  • FDA approved drug targets:Biotech drugs
Mediation Categories
Clinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

66 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
growth_factor_binderligand_regulatorGO_IntercellYesNoNoYesNo
ligand_regulatorligand_regulatorOmniPathYesNoNoYesNo
transmembranetransmembraneUniProt_locationNoNoNoYesNo
transmembranetransmembraneUniProt_topologyNoNoNoYesNo
transmembranetransmembraneUniProt_keywordNoNoNoYesNo
transmembrane_predictedtransmembraneOmniPathNoNoNoYesNo
transmembranetransmembraneGO_IntercellNoNoNoYesNo
transmembranetransmembraneCellPhoneDBNoNoNoYesNo
transmembranetransmembraneTopDBNoNoNoYesNo
transmembranetransmembraneLOCATENoNoNoYesNo
Page 4 of 7PreviousNext

Regulatory Interaction Network

16 records.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
SMUF1Q9HCE7BMPR2Q13873YesNoYesSIGNORSIGNOR:22298955SIGNOR:17317136
NOGGQ13253BMPR2Q13873YesNoYesSIGNORSIGNOR:22298955SIGNOR:12478285
BMR1AP36894BMPR2Q13873YesYesNoMPPIPhosphoPointSIGNORHPRDCui2007DIPWangDIP:10712517HPRD:10712517SIGNOR:10712517MPPI:10712517
BMPR2Q13873BMR1AP36894YesYesNoMPPISIGNORHPRDCui2007DIPWangMPPI:10712517SIGNOR:7791754DIP:10712517HPRD:10712517SIGNOR:10712517SIGNOR:18756288
CNEP1O95476BMPR2Q13873YesNoYesSIGNORSIGNOR:17141153
SMUF2Q9HAU4BMPR2Q13873YesNoYesSIGNORSIGNOR:22298955
Page 2 of 2Previous

Protein Complex Composition

12 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
ACVL1_BMPR2ACVRL1BMPR2P37023Q138731:1CellChatDBKEGG-MEDICUSCellPhoneDBICELLNETCellinkerCellPhoneDB:ACVL1_BMPR2178786072271017427481709
ACVR1/BMPR2ACVR1BMPR2Q04771Q138731:1CellChatDBKEGG-MEDICUSCellPhoneDBSIGNORICELLNETCellinkerCellPhoneDB:ACVR1_BMPR2SIGNOR:SIGNOR-C3027481709
ACVR1B_BMPR2ACVR1BBMPR2P36896Q138730:0CellinkerCellChatDB
BMPR1A/1B/2BMPR1ABMPR1BBMPR2O00238P36894Q138730:0:0SIGNORSIGNOR:SIGNOR-C29
BMPR1A_BMPR2BMPR1ABMPR2P36894Q138731:1CellChatDBKEGG-MEDICUSCellPhoneDBICELLNETCellinkerCellPhoneDB:BMPR1A_BMPR21843653327481709
BMPR1B_BMPR2BMPR1BBMPR2O00238Q138731:1CellChatDBKEGG-MEDICUSCellPhoneDBICELLNETCellinkerCellPhoneDB:BMPR1B_BMPR2178786071843653327481709
BMPR1B_BMPR2_ACVR1BACVR1BBMPR1BBMPR2O00238P36896Q138731:1:1CellPhoneDBICELLNETCellPhoneDB:BMPR1B_BMPR2_ACVR1B23382188
BMP2BMP7BMPR1ABMPR1BBMPR2NHP2SMAD6SMAD7TSC22D1O00238O15105O43541P12643P18075P36894Q13873Q15714Q9NX241:1:1:1:1:1:1:1:1NetworkBlastCompleatCompleat:HC8720
ACVRL1BMP10BMPR2O95393P37023Q138734:4:4PDBPDB:7ppc
BMP10BMPR2O95393Q138732:2PDBPDB:7ppaPDB:7ppb
Page 1 of 2Next

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass spectrometry129441425
Sequence, Structure & Domains

Sequences

Length
1,038
Mass
115,201
Sequence
MTSSLQRPWRVPWLPWTILLVSTAAASQNQERLCAFKDPYQQDLGIGESRISHENGTILCSKGSTCYGLWEKSKGDINLVKQGCWSHIGDPQECHYEECVVTTTPPSIQNGTYRFCCCSTDLCNVNFTENFPPPDTTPLSPPHSFNRDETIIIALASVSVLAVLIVALCFGYRMLTGDRKQGLHSMNMMEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLCKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDCESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQCAEERMAELMMIWERNKSVSPTVNPMSTAMQNERNLSHNRRVPKIGPYPDYSSSSYIEDSIHHTDSIVKNISSEHSMSSTPLTIGEKNRNSINYERQQAQARIPSPETSVTSLSTNTTTTNTTGLTPSTGMTTISEMPYPDETNLHTTNVAQSIGPTPVCLQLTEEDLETNKLDPKEVDKNLKESSDENLMEHSLKQFSGPDPLSSTSSSLLYPLIKLAVEATGQQDFTQTANGQACLIPDVLPTQIYPLPKQQNLPKRPTSLPLNTKNSTKEPRLKFGSKHKSNLKQVETGVAKMNTINAAEPHVVTVTMNGVAGRNHSVNSHAATTQYANGTVLSGQTTNIVTHRAQEMLQNQFIGEDTRLNINSSPDEHEPLLRREQQAGHDEGVLDRLVDRRERPLEGGRTNSNNNNSNPCSEQDVLAQGVPSTAADPGPSKPRRAQRPNSLDLSATNVLDGSSIQIGESTQDGKSGSGEKIKKRVKTPYSLKRWRPSTWVISTESLDCEVNNNGSNRAVHSKSSTAVYLAEGGTATTMVSKDIGMNCL
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=Q13873-1; Sequence=Displayed; Name=2; IsoId=Q13873-2; Sequence=VSP_054441, VSP_054442
Alternative Sequence
530; N -> R (in isoform 2); 531..1038; Missing (in isoform 2)

3D Structural Models

Turn
27..30; 42..47; 53..56; 105..109
Helix
48..50; 123..125; 200..202; 234..236; 237..247; 287..293; 298..315; 322..324; 380..382; 385..388; 394..396; 397..417; 421..423; 437..440; 446..453; 471..481; 488..490; 494..506
Beta Strand
33..35; 57..59; 66..73; 76..84; 90..92; 113..118; 203..211; 216..222; 225..233; 260..267; 273..279; 338..341; 347..349; 359..362
3D Structure
X-ray crystallography (7)

Domain & Motif Annotations

Compositional Bias
603..626; Low complexity; 872..896; Basic and acidic residues; 937..964; Polar residues
Domain (FT)
203..504; Protein kinase
Region
593..626; Disordered; 746..770; Disordered; 872..972; Disordered
Protein Families
  • Protein kinase superfamily
  • TKL Ser/Thr protein kinase family
  • TGFB receptor subfamily
Sequence Similarities
Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily.
Clinical Relevance
Disease Involvement
Disease variantFDA approved drug targets
Biomarker
Investigative
Drug Targets
FDA approved drug targets